Maturity-onset diabetes of the young with end-stage nephropathy: A new indication for simultaneous pancreas and kidney transplantation?

Transplantation

Volumn 77, Issue 8, 2004, Pages 1298-1300

  Saudek, Frantisek ^a   Průhová, Štěpánka ^b   Bouček, Petr ^a   Lebl, Jan ^b   Adamec, Miloš ^a   Ek, Jakob ^c   Pedersen, Oluf ^c   Hansen, Torben ^c  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; IMMUNOSUPPRESSIVE AGENT; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEAR FACTOR I; ORAL ANTIDIABETIC AGENT; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FAMILY HISTORY; GENE MUTATION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MATURITY ONSET DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 2342636369     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000119721.35506.a7     Document Type: Article

References (12)

1. Sutherland DER, Gruessner RW, Gruessner AC. Pancreas transplantation for treatment of diabetes mellitus. World J Surg 2001; 25: 487.
2. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000; 106: 329.
3. Cantarovich D, Murat A, Krempf M, et al. Simultaneous pancreas and kidney transplantation in a Type II (non-insulin-dependent) diabetic uremic patient requiring pregraft insulin therapy. Transplant Proc 1990; 22: 662.
4. International Pancreas Transplant Registry Newsletter. Minneapolis, University of Minnesota 2002.
5. Light LA, Sasaki TM, Currier CB, et al. Successful long-term kidney-pancreas transplants regardless of C-peptide status or race. Transplantation 2001; 71: 152.
6. Boutin P, Vasseur F, Samson C, et al. Routine mutation screening of HNF-1α and GCK genes in MODY diagnosis: how effective are the techniques of DHPLC and direct sequencing used in combination? Diabetologia 2001; 44: 775.
7. Pruhova S, Ek J, Lebl J, et al. Genetic epidemiology of MODY in the Czech Republic: new mutations in the MODY genes HNF-4α, GCK and HNF-1α. Diabetologia 2003; 46: 291.
8. Saudek F, Pelikánová T, Bartoš V, et al. Insulin action and insulin binding following pancreas transplantation. Diabetologie 1991; 34 (Suppl 1): S71.
9. Saudek F, Pelikánová T, Bartoš V, et al. The effect of insulin resistance on glucose tolerance after pancreas and kidney transplantation. Diab Metab Nutr 1993; 6: 283.
10. Covic AM, Schelling JR, Constantiner M, et al. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients. Kidney Int 2000; 58: 1742.
11. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345: 971.
12. Isomaa B, Henricsson M, Lehto M, et al. Chronic diabetic complications in patients with MODY 3 diabetes. Diabetologia 1998; 41: 467.